Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ADHXF > SEC Filings for ADHXF > Form 8-K on 27-Feb-2014All Recent SEC Filings

Show all filings for ADHEREX TECHNOLOGIES INC

Form 8-K for ADHEREX TECHNOLOGIES INC


27-Feb-2014

Other Events


Item 8.01 Other Events

On February 26, 2014, Adherex Technologies Inc. issued a press release announcing that the Children's Oncology Group (COG) posted top line results from its Study ACCL0431, A Randomized Phase III Study of Sodium Thiosulfate for the Prevention of Cisplatin-Induced Ototoxicity in Children. A copy of the press release is filed as Exhibit 99.1 to this Current Report.

Exhibit

99.1 Press Release issued by Adherex Technologies Inc. dated February 26, 2014, relating to its Sodium Thiosulfate clinical study update.

  Add ADHXF to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ADHXF - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.